Vesencumab (Anti-NRP1 / VEGF165R / CD304) | Read Reviews & Product Use Citations

Vesencumab (Anti-NRP1 / VEGF165R / CD304) is an IG1 antibody targeting neuropilin-1 (NRP-1). It has anti-angiogenic and anti-neoplastic activities and can be used in the research of metastatic solid tumors, including ovarian cancer and Diabetic macular edema (DME). MW :150 KD.

Purity & Quality Control

Batch: A268201 Purity: 99% Protein concentration: 11.69mg/ml Endotoxin Level: ＜1EU/mg

99

Biological Activity

Description	Vesencumab (Anti-NRP1 / VEGF165R / CD304) is an IG1 antibody targeting neuropilin-1 (NRP-1). It has anti-angiogenic and anti-neoplastic activities and can be used in the research of metastatic solid tumors, including ovarian cancer and Diabetic macular edema (DME). MW :150 KD.

References
[1] Jonathan Stephens, et al. Expert Opinion on Orphan Drugs. Volume 2, 2014 - Issue 8.

References

[1] Jonathan Stephens, et al. Expert Opinion on Orphan Drugs. Volume 2, 2014 - Issue 8.

Product Details

CAS No.	1205533-60-3
Molecular Weight	150
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field